Découvrez nos professeurs et professeures!

Revenir au répertoire
Fiche précédente
Fiche suivante

Marc-André Roy

Médecin clinicien enseignant titulaire

Marc-André Roy
marc-andre.roy@fmed.ulaval.ca
Centre d'études et d'interventions en santé mentale
Centre thématique de recherche en neurosciences
Centre de recherche CERVO
Partager la fiche :

Contribution à la recherche

Thématiques de recherche de la Faculté de médecine

  • Neurosciences et santé mentale
  • Santé des populations et pratiques optimales en santé
  • Transfert des connaissances

Projets de recherche en cours

  • Comprendre, Agir et Partager, pour soutenir le rétablissement des personnes composant avec un trouble psychotique - Fonds de recherche du Québec - Société et culture - Soutien aux équipes de recherche, chercheur principal - 2024-05-01 au 2028-03-31
  • Développement d'ateliers de neuroéducation sensibles aux traumas: une approche concertée et orientée vers les besoins et les perceptions de jeunes vulnérables - Conseil de recherches en sciences humaines du Canada, Université Laval - Fonds internes - Subvention de développement de partenariat, co-chercheur - 2024-03-22 au 2027-03-21
  • Comprendre l'utilisation excessive des écrans pour les jeux vidéo chez les jeunes avec un premier épisode psychotique: une nouvelle avenue vers leur rétablissement - Fonds de recherche du Québec - Société et culture - Action concertée |Programme de recherche sur l’utilisation des écrans et la santé des jeunes, chercheur principal - 2023-10-01 au 2027-01-01
  • Comprendre le lien entre le jeu problématique et les troubles psychotiques chez les jeunes: considérations post pandémiques, motivations et trajectoires. - Fonds de recherche du Québec - Société et culture - Action concertée | Programme de recherche sur les jeux de hasard et d’argent et autres dépendances, co-chercheur - 2023-07-01 au 2026-06-30
  • PAT-MOBILE (Psychosis And Trauma – Measurements of BIomarkers Levels in Exosomes) : étude multidimensionnelle des facteurs déterminants et exosomes comme indicateurs de pronostic et traitement - Université Laval - Fonds internes, Fonds de recherche du Québec - Santé - appel de propositions Initiative Stratégique en Santé Mentale (ISM): Mobiliser les forces vives en santé mentale et en neurosciences pour soutenir l’avancement des connaissances et la transformation des pratiques, co-chercheur - 2023-06-01 au 2026-05-31
  • Communiquer pour se rétablir: une approche innovante des difficultés communicationnelles dans les troubles psychotiques - Conseil de recherches en sciences humaines du Canada - Programme Savoir: Subventions Savoir, co-chercheur - 2022-04-01 au 2026-03-31
  • Impact du trouble du jeu vidéo sur l’évolution des patients atteints de premier épisode psychotique - MITACS Inc. - Accélération Québec (MITACS et gouvernement provincial), chercheur principal - 2023-05-01 au 2025-06-30

Financements des 2 dernières années

  • Entre jeux vidéo et jeux de hasard et d'argent: quand les jeunes atteints de troubles psychotiques franchissent la ligne - Instituts de recherche en santé du Canada - Subvention catalyseur : Répercussions des jeux vidéo et de hasard sur la santé, co-chercheur - 2024-03-01 au 2025-02-28
  • Comprendre, Agir et Partager (CAP) pour soutenir le Rétablissement global des personnes aux prises avec un trouble psychotique - Fonds de recherche du Québec - Société et culture - Soutien aux équipes de recherche, chercheur principal - 2020-05-01 au 2024-04-30
  • Impact des déficits cognitifs et communicationnels sur la prise de décision partagée en schizophrénie - CIUSSS - CN - VITAM Centre de recherche en santé durable - Fonds stratégique de développement de la recherche, co-chercheur - 2023-02-08 au 2024-03-31
  • Comprendre le lien entre le jeu problématique et les troubles psychotiques chez les jeunes : une nouvelle voie vers le rétablissement - Fonds de recherche du Québec - Société et culture - Action concertée - Programme de recherche sur les impacts socioéconomiques des jeux de hasard et d'argent, co-chercheur - 2020-03-01 au 2023-06-01
  • Télé-NEUROS (Nouvel Environnement Universitaire de Recherche Orchestrée en Santé mentale et cognitive: une télé initiative) - CIUSSS - CN - CIRRIS, Université Laval - Fonds internes, CIUSSS - CN - CERVO, co-chercheur - 2020-10-20 au 2021-03-31

Publications

  • A Rapid-Learning Health System to Support Implementation of Early Intervention Services for Psychosis in Quebec, Canada: Protocol., Abdel-Baki A, Roy MA, LeBlanc A, Iyer S, Ferrari M, JMIR research protocols, 2022, 10.2196/37346
  • Using a learning health system to integrate Peer Support in Early Intervention Services for psychosis in Quebec: Protocol for a Participatory, Mixed-Methods Study (the PAIRPEP project), Amal Abdel-Baki, Mary Anne Levasseur, Annie Bosséᵃ, Gabriel Julienᵃ, Julie Marguerite Deschênesᵃ, Marie-Helene Morin, Marc-André Roy, Manuela Ferrari, Srividya Iyer, Beatrice Todescoᵃ, 2025, 10.22541/au.174738435.53307949/v1
  • [Early Intervention for Psychosis from Past to Future: Overcoming Implementation Challenges to Maximize its Impact?], McGorry P, Conus P, Abdel-Baki A, Roy MA, Malla A, Sante mentale au Quebec, 2021
  • Validation francophone de la CASIG-rev – un outil clinique visant à soutenir le rétablissement des personnes avec un trouble psychiatrique: French validation of the CASIG-rev – a clinical personal recovery assessment for people with psychiatric disorders, Marc Corbière, Amal Abdel-Baki, Marc-André Roy, Paméla Power, Audrey Livet, Yasser Khazaal, Stéphane Raffard, Isabelle Heyden, Tania Lecomte, The Canadian Journal of Psychiatry, 2024, 10.1177/07067437241261481
  • Problem Gambling Associated with Aripiprazole: A Nested Case-Control Study in a First-Episode Psychosis Program., Roy MA, Demers MF, Jacques C, Giroux I, Carmichael PH, Dorval M, Corbeil S, Corbeil O, CNS drugs, 2021, 10.1007/s40263-021-00801-4
  • Psychotic Disorders and exosomes: An overview of current evidence and future directions, Jessica Deslauriers, Marc-André Roy, Marie-France Demers, Sébastien Brodeur, Laurent Béchard, Maxime Huot-Lavoie, Olivier Corbeil, Charles Desmeules, Psychiatry Research, 2024, 10.1016/j.psychres.2024.116066
  • Assessing the Fidelity of Supported Education Programs for First-Episode Psychosis To the Supported Employment Guidelines Adapted for Education, Caroline Cellard, Marc-André Roy, Andréanne Simard, Amal Abdel-Baki, Marc Corbière, Tania Lecomte, Élisabeth Thibaudeau, 2024, 10.22541/au.170664370.07864309/v1
  • Management of Rhabdomyolysis in a Patient Treated with Clozapine: A Case Report and Clinical Recommendations., Demers MF, Demers MF, Roy MA, Turgeon-Fournier A, Mailhot MP, Boulanger C, Assaad I, Thivierge MA, Corbeil O, Béchard L, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2022, 10.9758/cpn.2022.20.1.194
  • Association between previous and future antipsychotic adherence in patients initiating clozapine: real-world observational study., Roy MA, Béchard L, Corbeil O, Demers MF, Lesage A, Fleury MJ, Stip E, Courteau M, Vanasse A, Courteau J, Brodeur S, The British journal of psychiatry : the journal of mental science, 2022, 10.1192/bjp.2022.1
  • Treating Depression Following Biliopancreatic Diversion With Duodenal Switch Surgery: A Case Report., Demers MF, Roy MA, Plante M, Corbeil O, Giroux I, Béchard L, Journal of clinical psychopharmacology, 2022, 10.1097/jcp.0000000000001504
  • Evaluating romantic and sexual functioning among persons with psychosis: Reliability and validity of two measures., Lecomte T, Lepage M, Abdel-Baki A, Roy MA, Murphy C, Diotte F, Cloutier B, Psychiatric rehabilitation journal, 2022, 10.1037/prj0000544
  • M59. THE ASSOCIATIONS BETWEEN THEORY OF MIND AND NEUROCOGNITION IN RECENT ONSET PSYCHOSIS, Cellard C, Roy M, Vallières C, Achim A, Turcotte M, Lavoie A, Pothier W, Thibaudeau É, Schizophrenia bulletin, 2020
  • M197. SEASONAL ANTIPSYCHOTICS IN SCHIZOPHRENIA: OUTCOMES IN NATURALISTIC SETTINGS (SEASONS STUDY) OBSERVATIONAL RETROSPECTIVE MULTICENTRE CANADIAN STUDY ON 3MONTH-FORMULATION OF LONG-ACTING INJECTABLE PALIPERIDONE PALMITATE, Corbeil O, Roy M, Demers M, Rhéaume G, Rosebush-Mercier R, Essiambre A, Corbeil O, Schizophrenia bulletin, 2020
  • For a structured response to the psychosocial consequences of the restrictive measures imposed by the global COVID-19 health pandemic: The MAVIPAN longitudinal prospective cohort study protocol, Savard C, Déry M, Côté N, Collin-Vézina D, Cellard C, De Koninck Y, Hébert M, Després J, Mercier C, Routhier F, Tarabulsy G, Blouin P, Baron M, LeBlanc A, 2020, 10.1101/2020.11.10.20227397
  • Evaluating preferences for online psychological interventions to decrease cannabis use in young adults with psychosis: An observational study, Didier Jutras-Aswad, Marie Villeneuve, Sophie L'Heureux, Clairélaine Ouellet-Plamondon, José Côté, Tania Lecomte, Benedikt Fischer, Jan Copeland, Marc-André Roy, David Crockford, Philip G. Tibbo, Arash Bahremand, Hamzah Bakouni, Alina Dyachenko, Amal Abdel-Baki, Ovidiu Tatar, Psychiatry Research, 2023, 10.1016/j.psychres.2023.115276
  • Gaming Disorder and Psychotic Disorders: A Scoping Review., Roy MA, Khazaal Y, Giroux I, Cayouette A, Anderson E, Essiambre AM, Fournier É, Massé C, Brodeur S, Corbeil O, Béchard L, Gabriel-Courval M, Huot-Lavoie M, Psychopathology, 2022, 10.1159/000527143
  • From QAAPAPLE 1 to QAAPAPLE 2: how do we move from one algorithm to another one with Long Acting Antipsychotics (LAIs)., Arnone D, Javaid SF, Abdel Aziz K, Amiri L, Osman O, Bloom D, Roy MA, Grignon S, Stip E, Expert review of neurotherapeutics, 2020, 10.1080/14737175.2020.1826930
  • "Real world" clinical effectiveness of paliperidone palmitate 3-monthly injectable in early psychosis patients., Abdel-Baki A, Roy MA, Demers MF, Lafrenière S, Ferraro V, Psychopharmacology, 2020, 10.1007/s00213-020-05656-z
  • [A Healthy Mind in a Healthy Body: The Value of Physical Activity for Youth With First Episode Psychosis]., Roy MA, Abdel-Baki A, Ouellet-Plamondon C, Kern L, Piché F, Bernard P, Romain AJ, Sante mentale au Quebec, 2021
  • Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series., Demers MF, Roy MA, Lafrenière CÉ, Thivierge MA, Plante M, Corbeil O, Béchard L, Journal of psychopharmacology (Oxford, England), 2021, 10.1177/02698811211029737
  • For a structured response to the psychosocial consequences of the restrictive measures imposed by the global COVID-19 health pandemic: the MAVIPAN longitudinal prospective cohort study protocol., MAVIPAN Research Collaboration, Dionne É, Côté N, Collin-Vézina D, Cellard C, De Koninck Y, Hébert M, Despres JP, Mercier C, Routhier F, Tarabulsy G, Blouin P, Baron M, LeBlanc A, BMJ open, 2022, 10.1136/bmjopen-2021-048749
  • What areas of everyday functioning are affected by theory of mind deficits in recent-onset schizophrenia spectrum disorders? , Roy MA, Cellard C, Huot A, Thibaudeau É, Achim AM, Early intervention in psychiatry, 2022, 10.1111/eip.13291
  • SARPEP, a rapid-learning healthcare system of early intervention services for psychosis in Quebec, Canada: Feasibility, acceptability and early impacts, Srividya N. Iyer, Marc-André Roy, Daniel Rabouin, Camille Arbaud, Annie Leblanc, Manuela Ferrari, Amal Abdel-Baki, Schizophrenia Research, 2025, 10.1016/j.schres.2025.02.001
  • Continuing clozapine despite recurrent neutropenia: A 8 year follow-up case report with granulocyte-colony stimulating factor as-required use., Roy MA, Breault AS, Corbeil O, Fortier L, Demers MF, Asian journal of psychiatry, 2018, 10.1016/j.ajp.2018.10.005
  • [Long-acting antipsychotics: The QAAPAPLE algorithm review]., Grignon S, Bloom D, Roy MA, Abdel-Baki A, Stip E, Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2019, 10.1177/0706743719847193
  • O5.4. PROBLEM GAMBLING ASSOCIATED WITH ARIPIPRAZOLE: A NESTED CASE-CONTROL STUDY IN A FIRST-EPISODE PSYCHOSIS COHORT USING A SYSTEMATIC PHARMACOVIGILANCE APPROACH, Demers M, Roy M, Chalifour G, Breault A, Corbeil S, Corbeil O, Schizophrenia bulletin, 2019
  • F5. CIRCULATING IGFBP-2 LEVELS REVEAL ATHEROGENIC METABOLIC RISK IN SCHIZOPHRENIC PATIENTS USING ATYPICAL ANTIPSYCHOTICS, Picard F, Demers M, Bouchard R, Roy M, Després J, Alméras N, Rauzier C, Nolin M, Schizophrenia bulletin, 2019
  • O12.2. CLOZAPINE RE-CHALLENGE OR CONTINUATION FOLLOWING A NEUTROPENIA: CASE-SERIES OF 22 CASES, Marie-France D, Corbeil O, Essiambre A, Chalifour G, Breault A, Nadeau M, Malenfant E, Morasse-Bégin M, Roy M, Schizophrenia bulletin, 2019
  • Clozapine Rechallenge or Continuation Despite Neutropenia, an Extended Follow-up of a Consecutive Quebec Case Series., Roy MA, Demers MF, Essiambre AM, Huot-Lavoie M, Brodeur S, Malenfant E, Hakim JR, Corbeil O, Morasse-Bégis M, Béchard L, Journal of clinical psychopharmacology, 2022, 10.1097/jcp.0000000000001556
  • Letter to the Editor: Correction About the Nursing Delirium Screening Scale in Response to: "A Study of the Psychometric Properties of the "Stanford Proxy Test for Delirium" (S-PTD): A New Screening Tool for the Detection of Delirium"., Le Moignan Moreau J, Roy MA, Gaudreau JD, Gagnon P, Psychosomatics, 2020, 10.1016/j.psym.2020.05.019
  • T50. DETERMINANTS OF OCCUPATIONAL RECOVERY IN RECENT-ONSET PSYCHOSIS: THE ROLE OF COGNITION, Vallières C, Turcotte M, Lavoie A, Achim A, Villotti P, Corbière M, Cellard C, Roy M, Schizophrenia bulletin, 2019
  • The other side of the social interaction: Theory of mind impairments in people with schizophrenia are linked to other people's difficulties in understanding them., Fossard M, Roy MA, Achim AM, Schizophrenia research, 2022, 10.1016/j.schres.2022.07.001
  • Case Reports of Aripiprazole and Problematic Gambling in Schizophrenia: A Critical Review of the Evidence., Demers MF, Roy MA, Breault AS, Chalifour G, Corbeil S, Corbeil O, Lachance A, Journal of clinical psychopharmacology, 2019, 10.1097/jcp.0000000000001068
  • Comparative effectiveness and safety of antipsychotic drugs in patients with schizophrenia initiating or reinitiating treatment: A Real-World Observational Study., Roy MA, Courteau M, Fleury MJ, Lesage A, Stip E, Courteau J, Vanasse A, Brodeur S, Acta psychiatrica Scandinavica, 2022, 10.1111/acps.13413
  • S1. CLOZAPINE RECHALLENGE FOLLOWING NEUTROPENIA USING GRANULOCYTE COLONY-STIMULATING FACTOR: A QUEBEC CASE SERIES, Corbeil O, Demers M, Roy M, Lafrenière C, Thivierge M, Plante M, Corbeil O, Béchard L, Schizophrenia bulletin, 2020
  • The Evolution of Long-Acting Antipsychotics Use in Québec between 2003 and 2017., Roy MA, Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2020, 10.1177/0706743720901975
  • Housing trajectories and the risk of homelessness among new mental health service users: Protocol for the AMONT study, Marc‐André Roy, Eric Latimer, Mathieu Dostie, Luigi de Benedictis, Anne Crocker, Félix‐Antoine Bérubé, Amal Abdel‐Baki, Laurence Roy, Early Intervention in Psychiatry, 2023, 10.1111/eip.13344
  • [Family Approaches in Early Intervention: Benchmarks to Guide Intervention and Support Families in First Episode Psychosis Programs (FEPP)]., Roy MA, Iyer SN, Levasseur MA, Bergeron AS, Morin MH, Sante mentale au Quebec, 2021
  • A Chart Audit Study of Clozapine Utilization in Early Psychosis., Roy MA, Tibbo P, Williams R, Bilodeau I, Bardell A, Demers MF, Leclerc LD, Journal of clinical psychopharmacology, 2021, 10.1097/jcp.0000000000001384
  • Real-world effectiveness of aripiprazole once-monthly REACT study: Pooled analysis of two noninterventional studies., Wiedemann K, Therrien F, Roy MA, Oluboka O, Janetzky W, Clerzius G, Schöttle D, European psychiatry : the journal of the Association of European Psychiatrists, 2022, 10.1192/j.eurpsy.2022.27
  • Use of reference markers in the speech of people with schizophrenia spectrum disorders: Evidence from two referential communication tasks manipulating common ground with the interaction partner, Marion Fossard, Souleymane Gadio, Marc-André Roy, Dominique Knutsen, Amélie M. Achim, Schizophrenia Research: Cognition, 2025, 10.1016/j.scog.2024.100343
  • F114. THE EVOLUTION OF LONG-ACTING ANTIPSYCHOTICS USE IN QUEBEC BETWEEN 2003 AND 2017, Antoine L, Roy M, Schizophrenia bulletin, 2019
  • A multimodal attempt to follow-up linkage regions using RNA expression, SNPs and CpG methylation in schizophrenia and bipolar disorder kindreds., Bureau A, Roy MA, Fournier A, Croteau J, Paccalet T, Maziade M, Chagnon YC, European journal of human genetics : EJHG, 2019, 10.1038/s41431-019-0526-y
  • [Detecting and Treating Comorbid Disorders in First-Episode Psychosis: A Lever for Recovery]., Roy MA, Artaud L, Bérubé FA, Corbeil O, Sante mentale au Quebec, 2021
  • Personalized cognitive remediation therapy to facilitate return to work or to school in recent-onset psychosis., Cellard C, Chagnon Y, Reeder C, Wykes T, Achim AM, Thibaudeau É, Corbière M, Roy MA, Pothier W, Neurocase, 2020, 10.1080/13554794.2020.1841797
  • Determinants of occupational outcome in recent-onset psychosis: The role of cognition., Roy MA, Turcotte M, Vallières C, Lavoie A, Achim AM, Villotti P, Corbière M, Cellard C, Pothier W, Schizophrenia research. Cognition, 2019, 10.1016/j.scog.2019.100158
  • Effect of Cannabis Legalization in Canada on the Incidence of Psychosis Consultations in Quebec City's Psychiatric Emergency Services, Marc-André Roy, Bruno-Pier Blouin, Christina Bergeron, Audrey Bergeron, Maxime Huot-Lavoie, Sophie L’Heureux, The Canadian Journal of Psychiatry, 2024, 10.1177/07067437241232901
  • A Rapid Learning Health System to Support Implementation of Early Intervention Services for Psychosis in Quebec, Canada: Study Protocol, Abdel-Baki A, Roy M, Leblanc A, Iyer S, Ferrari M, 2021, 10.21203/rs.3.rs-1104367/v1
  • [Psychopharmacology of First Episode Psychosis: An Approach Based on Recovery]., Demers MF, Roy MA, Stip E, Lehoux C, Malenfant E, Corbeil O, Béchard L, Sante mentale au Quebec, 2021
  • Multidimensional analysis of adult patients' care trajectories before a first diagnosis of schizophrenia., Lesage A, Brodeur S, Fleury MJ, Stip E, Roy MA, Courteau M, Courteau J, Vanasse A, Schizophrenia (Heidelberg, Germany), 2022, 10.1038/s41537-022-00256-6
  • Intervenir auprès des jeunes atteints de premier épisode psychotique : un recueil de savoirs et d’expériences en francophonie québécoise., Abdel-Baki A, Roy MA, Sante mentale au Quebec, 2021
  • Problem Gambling Associated With Aripiprazole in First-Episode Psychosis Patients: A Series of 6 Case Reports., Roy MA, Demers MF, Dorval M, Jacques C, Giroux I, Corbeil S, Corbeil O, Journal of clinical psychopharmacology, 2020, 10.1097/jcp.0000000000001177
  • S110. LONG-ACTING ARIPIPRAZOLE IN FIRST-EPISODE PSYCHOSIS: DOES ONE SIZE FIT ALL?, Roy M, Demers M, Vallières C, L’Heureux S, Bouffard A, Fraser C, Rioux S, Tremblay M, Schizophrenia bulletin, 2019
  • Assessing the fidelity of supported education programs for first‐episode psychosis to the supported employment guidelines adapted for education, Caroline Cellard, Marc‐André Roy, Andréanne Simard, Amal Abdel‐Baki, Marc Corbière, Tania Lecomte, Elisabeth Thibaudeau, Early Intervention in Psychiatry, 2024, 10.1111/eip.13533
  • Urbanicity, Schizophrenia and Equitable Specialist Services Allocation., Vanasse A, Roy MA, Courteau M, Fleury MJ, Stip E, Brodeur S, Courteau J, Lesage A, Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2021, 10.1177/07067437211040606
  • Antipsychotic utilization trajectories three years after initiating or reinitiating treatment of schizophrenia: A state sequence analysis approach., Roy MA, Demers MF, Lesage A, Fleury MJ, Stip E, Courteau M, Courteau J, Vanasse A, Brodeur S, Acta psychiatrica Scandinavica, 2022, 10.1111/acps.13411
  • Circulating IGFBP-2 levels reveal atherogenic metabolic risk in schizophrenic patients using atypical antipsychotics., Picard F, Alméras N, Roy MA, Després JP, Cadrin C, Bouchard RH, Rauzier C, Demers MF, Nolin MA, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2020, 10.1080/15622975.2020.1770858
  • [From Kraepelin to McGorry: Scientific Vision and Experiential Narrative around a Major Paradigmatic Shift]., Cambon A, Olivier D, Roy MA, Sante mentale au Quebec, 2021
  • Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation., Roy MA, Demers MF, Tibbo P, Melun JP, Crocker C, Thériault C, Chandrasena R, Brodeur S, Huot-Lavoie M, Roy AA, Béchard L, Essiambre AM, Corbeil O, Therapeutic advances in psychopharmacology, 2022, 10.1177/20451253221136021
  • A Rapid-Learning Health System to Support Implementation of Early Intervention Services for Psychosis in Quebec, Canada: Protocol (Preprint), Amal Abdel-Baki, Marc-André Roy, Annie LeBlanc, Srividya Iyer, Manuela Ferrari, 2022, 10.2196/preprints.37346
  • Risk factors for homelessness and housing instability in the first episode of mental illness: Initial findings from the AMONT study, Marc‐André Roy, Eric Latimer, Esther Thibeault, Felix‐Antoine Bérubé, Luigi de Benedictis, Amal Abdel‐Baki, Anne G. Crocker, Marichelle Leclair, Laurence Roy, Early Intervention in Psychiatry, 2024, 10.1111/eip.13495
  • More intensive probing increases the detection of social anxiety disorders in schizophrenia., Achim AM, Demers MF, Leclerc LD, Lehoux C, Vallières C, Roy MA, Psychiatry research, 2018, 10.1016/j.psychres.2018.07.032

Contribution à l'enseignement aux cycles supérieurs

Étudiant(e)s dirigé(e)s*

Depuis 2020/05
  • Olivier Corbeil - Doctorat - En cours
  • Maxime Huot Lavoie - Doctorat - En cours
  • Andréanne Lavoie - Doctorat - 2021/05
  • Anne-Marie Essiambre - Maîtrise avec mémoire - 2024/05

Encadrement d'étudiant(e)s

Direction de recherche dans les domaines suivants :

  • Épidémiologie
  • Neurobiologie — Neurosciences
  • Sciences cliniques et biomédicales

En savoir plus sur les programmes

Disponibilité d'encadrement d'étudiant(e)s

Ce (cette) professeur(e) est présentement à la recherche d'étudiant(e)s.

Envoyer un courriel
*Les supervisions d’étudiant(e)s de 1er cycle en stage de recherche et de résident(e)s aux études médicales postdoctorales seront répertoriées ultérieurement.
Mettre à jour mon profil de professeur(e)